Skip to content
Catalyst

Serenoa repensFinding

Serenoa repens increases maximum urinary flow rate (Qmax, peak flow)

raisesStrong evidenceFindingreplicated ×1

01 · The sentence it was drawn from

“S. repens may result in an increase in Qmax compared to placebo at 2 to 6 months follow-up (MD 1.16, 95% CI 0.47 to 1.84; 1,833 participants; 13 studies; I2=75%), however this effect dissolve at 12 to 17 month follow-up (MD 0.26, 95% CI −0.22 to 0.74; n=1,019; 5 studies; I2=0%).”
Quoted verbatim from Serenoa repens for the treatment of lower urinary tract symptoms due to benign prostatic enlargement: A systematic review and meta-analysis.
This finding among the 3 findings on its endpoint

Serenoa repens

Maximum urinary flow rate (Qmax, peak flow)

raises

Effect as reported

1.16mean difference

CI 0.47 to 1.84

Who
n = 1,833 · Men aged 45 years and over with lower urinary tract symptoms due to benign prostatic enlargement; main comparison, S. repens extract versus placebo; short-term follow-up 2 to 6 months, 13 pooled studies
Dose studied
not reported

Strong evidencePMID 34488251 · 2022

02 · The study

Study
meta-analysis
Participants
1,833
Duration
not reported

Evidence, by strength

  • strongthis finding
  • moderate
  • limited
  • very limited
  • insufficient

03 · The paper

Investigative and clinical urology
What else it reported1 finding · 0 compounds · 1 endpoint

04 · To cite this finding

This address does not change

https://catalystproject.ai/e/01M6Y19SC3SCDHY804TFMJ0ZR1